The influence of diabetes and hypertension on outcome in COVID-19 patients: Do we mix apples and oranges?
作者信息
Tadic Marijana, Cuspidi Cesare
机构信息
University Hospital "Dr. Dragisa Misovic-Dedinje" Department of Cardiology, Belgrade, Serbia.
University of Milan-Bicocca, Milan, Italy.
出版信息
J Clin Hypertens (Greenwich). 2021 Feb;23(2):235-237. doi: 10.1111/jch.14145. Epub 2020 Dec 25.
Abstract
摘要
相似文献
1
The influence of diabetes and hypertension on outcome in COVID-19 patients: Do we mix apples and oranges?
J Clin Hypertens (Greenwich). 2021 Feb;23(2):235-237. doi: 10.1111/jch.14145. Epub 2020 Dec 25.
2
Is hypertension without any other comorbidities an independent predictor for COVID-19 severity and mortality?
J Clin Hypertens (Greenwich). 2021 Feb;23(2):232-234. doi: 10.1111/jch.14144. Epub 2020 Dec 23.
3
Utilizing Mobile Health Units for Mass Hypertension Screening in Socially Vulnerable Communities Across Detroit.
Hypertension. 2022 Jun;79(6):e106-e108. doi: 10.1161/HYPERTENSIONAHA.122.19088. Epub 2022 Mar 16.
4
[Diabetes and hypertension as factors associated with Covid-19 lethality in Sonora, Mexico, 2020].
Salud Publica Mex. 2020 Sep-Oct;62(5):456-457. doi: 10.21149/11546.
5
Characteristics of COVID-19 at a non-COVID tertiary pulmonary care centre in Delhi, India.
Monaldi Arch Chest Dis. 2020 Nov 9;90(4). doi: 10.4081/monaldi.2020.1568.
6
Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
Public Health. 2020 Dec;189:66-72. doi: 10.1016/j.puhe.2020.09.014. Epub 2020 Sep 30.
7
Prevalence of Systemic Arterial Hypertension and Diabetes Mellitus in Individuals with COVID-19: A Retrospective Study of Deaths in Pernambuco, Brazil.
Arq Bras Cardiol. 2021 Aug;117(2):416-422. doi: 10.36660/abc.20200885.
8
Fangcang shelter hospitals in COVID-19 pandemic: the practice and its significance.
Clin Microbiol Infect. 2020 Aug;26(8):976-978. doi: 10.1016/j.cmi.2020.04.038. Epub 2020 May 1.
9
No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity.
Clin Res Cardiol. 2021 Jan;110(1):146-147. doi: 10.1007/s00392-020-01653-6. Epub 2020 Apr 23.
10
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
引用本文的文献
1
Prevalence of Hypertension and Diabetes in Severe COVID-19: A Cross-Sectional Study from Single Center, Kabul [Letter].
Infect Drug Resist. 2024 May 31;17:2225-2226. doi: 10.2147/IDR.S477018. eCollection 2024.
2
Disease Outcomes of COVID-19 in Diabetic and Hypertensive Patients During the Hospital Stay.
Cureus. 2023 Oct 13;15(10):e46943. doi: 10.7759/cureus.46943. eCollection 2023 Oct.
3
Effects of Hypertension Alone and in Comorbidity with Diabetes on Death within 30 Days among Inpatients with COVID-19 Infection.
J Res Health Sci. 2022 Dec;22(4):e00565. doi: 10.34172/jrhs.2022.100.
4
COVID-19 Viral Infection Presenting With Diabetic Ketoacidosis, Hyperosmolar Hyperglycemic Syndrome, or Mixed Hyperglycemic Crisis: A Case Series.
J Community Hosp Intern Med Perspect. 2023 Mar 10;13(2):76-83. doi: 10.55729/2000-9666.1163. eCollection 2023.
5
Factors Affecting Confirmed COVID-19 Patient's Recovery Time at King Abdulaziz Medical City, Jeddah.
Cureus. 2023 Jan 24;15(1):e34130. doi: 10.7759/cureus.34130. eCollection 2023 Jan.
6
Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients.
Pharmaceutics. 2022 Aug 30;14(9):1828. doi: 10.3390/pharmaceutics14091828.
7
Diabetic ketoacidosis amongst patients with COVID-19: A retrospective chart review of 220 patients in Pakistan.
Endocrinol Diabetes Metab. 2022 May;5(3):e00331. doi: 10.1002/edm2.331. Epub 2022 Feb 24.
8
Severity of coronavirus disease 19: Profile of inflammatory markers and (rs4646994) and (rs2285666) gene polymorphisms in Iraqi patients.
Meta Gene. 2022 Feb;31:101014. doi: 10.1016/j.mgene.2022.101014. Epub 2022 Jan 10.
9
Respiratory Pathophysiology of Mechanically Ventilated COVID-19 Patients.
Cureus. 2021 Dec 6;13(12):e20218. doi: 10.7759/cureus.20218. eCollection 2021 Dec.
本文引用的文献
1
Independent and combined effects of hypertension and diabetes on clinical outcomes in patients with COVID-19: A retrospective cohort study of Huoshen Mountain Hospital and Guanggu Fangcang Shelter Hospital.
J Clin Hypertens (Greenwich). 2021 Feb;23(2):218-231. doi: 10.1111/jch.14146. Epub 2020 Dec 25.
2
Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study.
BMC Med. 2020 Nov 16;18(1):359. doi: 10.1186/s12916-020-01832-2.
3
Predictors of mortality in patients with COVID-19-a systematic review.
Eur J Integr Med. 2020 Dec;40:101226. doi: 10.1016/j.eujim.2020.101226. Epub 2020 Oct 17.
4
Influence of blood pressure control and application of renin-angiotensin-aldosterone system inhibitors on the outcomes in COVID-19 patients with hypertension.
J Clin Hypertens (Greenwich). 2020 Nov;22(11):1974-1983. doi: 10.1111/jch.14038. Epub 2020 Oct 2.
5
Association of Hypertension with All-Cause Mortality among Hospitalized Patients with COVID-19.
J Clin Med. 2020 Sep 28;9(10):3136. doi: 10.3390/jcm9103136.
6
Prevalence of Diabetes and Hypertension and Their Associated Risks for Poor Outcomes in Covid-19 Patients.
J Endocr Soc. 2020 Jul 21;4(9):bvaa102. doi: 10.1210/jendso/bvaa102. eCollection 2020 Sep 1.
7
Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis.
Diabetol Metab Syndr. 2020 Aug 31;12:75. doi: 10.1186/s13098-020-00586-4. eCollection 2020.
8
Blood pressure control and adverse outcomes of COVID-19 infection in patients with concomitant hypertension in Wuhan, China.
Hypertens Res. 2020 Nov;43(11):1267-1276. doi: 10.1038/s41440-020-00541-w. Epub 2020 Aug 27.
9
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.
Diabetes Res Clin Pract. 2020 Oct;168:108374. doi: 10.1016/j.diabres.2020.108374. Epub 2020 Aug 15.
10
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study.
Lancet Diabetes Endocrinol. 2020 Oct;8(10):823-833. doi: 10.1016/S2213-8587(20)30271-0. Epub 2020 Aug 13.
Zotero 插件